Anti-PYY (3-36) (peptide tyrosine-tyrosine amide, 3-36) Antibody (4)
Our mouse PYY (3-36) (peptide tyrosine-tyrosine amide, 3-36) monoclonal antibody from Antibodies Incorporated is produced in-house from clone 4. It detects human PYY (3-36) (peptide tyrosine-tyrosine amide, 3-36) and is Protein A or Protein G purified. Works in ELISA, WB.
SKU: ABS 051-04-010
Ships: 1-2 business days
Product Details
PYY (3-36) (peptide tyrosine-tyrosine amide, 3-36)
Peptide tyrosine-tyrosine amide (3-36), or PYY(3-36), is a major metabolite of the gut hormone PYY and is produced by the action of dipeptidyl peptidase IV on PYY in the intestinal brush border and in the circulation. PYY(3-36) is a potent inhibitor of food intake in rats and humans, acting selectively on the Y2 receptor to inhibit orexigenic NPY neurons in the arcuate nucleus, thus disinhibiting anorexigenic POMC neurons. The anorexigenic effect of PYY(3-36) is additive to that of the co-secreted gut hormone GLP-1.
Protein A or Protein G purified
1 mg/mL ±15%
Monoclonal
4
IgG2a/k
ELISA, WB
Mouse
PYY
4 kDa
Synthetic N-terminal fragment of human PYY(3-36) coupled to carrier.
Human
Human
2-8°C without exposure to light
Liquid
BSA free
0.01 M phosphate buffer, pH 7.4, with 0.5 M NaCl and 15 mM sodium azide
ELISA: 1:20,000
ABS 051-04 binds free PYY(3-36) in solution. An ELISA dilution guideline of 1/20,000 applies to PYY(3-36) coated directly at 1 μg/mL. ABS 051-04 as a capture antibody forms a sandwich ELISA antibody pair with biotinylated ABS 029-01 as a detection antibody for measuring PYY(3-36).
Unconjugated
ABS 051-04 binds human PYY(3-36). Based on inhibition ELISA, ABS 051-04 shows no cross-reaction with PYY(1-36) or NPY. The epitope lies within residues 3-12 of human PYY.
These antibodies are to be used as research laboratory reagents and are not for use as diagnostic or therapeutic reagents in humans.
United States
24 months from date of receipt
PYY; Peptide YY; PYY-I; Peptide tyrosine tyrosine; Cleaved into: Peptide YY(3-36; PYY-II; PYY1; prepro-PYY
[Peptide YY]: Ligand for neuropeptide Y receptor type 1 (NPY1R) and neuropeptide Y receptor type 2 (NPY2R) (PubMed:1317848, PubMed:7592910, PubMed:36525977). Also binds NPY5R (By similarity). Receptor binding induces adenylate cyclase-inhibiting G protein-coupled receptor signaling, resulting in inhibition of cAMP production (PubMed:1317848, PubMed:7592910). Receptor activation by PYY also leads to an increase of intracellular Ca(2+) levels (PubMed:1317848, PubMed:36525977, PubMed:7592910). This gut peptide inhibits exocrine pancreatic secretion (By similarity). Involved in the regulation of colonic antisecretory tone, and colonic contractility (By similarity). {ECO:0000250|UniProtKB:P68005, ECO:0000250|UniProtKB:Q9EPS2, ECO:0000269|PubMed:1317848, ECO:0000269|PubMed:36525977, ECO:0000269|PubMed:7592910}.; [Peptide YY(3-36)]: Is a NPY2R agonist involved in the down-regulation of appetite and food intake, probably acting on receptors located on proopiomelanocortin(POMC)-releasing and neuropeptide Y(NPY)-releasing neurons in the arcuate nucleus of hypothalamus (PubMed:12167864). In NPY-releasing neurons, NPY2R activation by PYY(3-36) leads to membrane hyperpolarization and reduced release of the orexigenic neuropeptide NPY (By similarity). {ECO:0000250|UniProtKB:Q9EPS2, ECO:0000269|PubMed:12167864}.
5697
Shipped on ice packs

